Enhancing myocardial salvage and regeneration as adjuncts to reperfusion therapy: Unresolved issues after myocardial infarction

Overgaard, 2009, Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: results from the STEMMI trial, Int J Cardiol Schömig, 2008, Percutaneous coronary interventions in acute ST-segment elevation myocardial infarction, 321 Canty, 2008, Coronary blood flow and myocardial ischemia, 1167 Nian, 2004, Inflammatory cytokines and postmyocardial infarction remodeling, Circ Res, 94, 1543, 10.1161/01.RES.0000130526.20854.fa Moens, 2005, Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process, Int J Cardiol, 100, 179, 10.1016/j.ijcard.2004.04.013 Yellon, 2007, Myocardial reperfusion injury, N Engl J Med, 357, 1121, 10.1056/NEJMra071667 Ross, 2005, A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II), J Am Coll Cardiol, 45, 1775, 10.1016/j.jacc.2005.02.061 Kopecky, 2003, Am Heart J, 146, 146, 10.1016/S0002-8703(03)00172-8 Díaz, 2007, Glucose–insulin–potassium therapy in patients with ST-segment elevation myocardial infarction, JAMA, 298, 2399, 10.1001/jama.298.20.2399 Mehta, 2005, Effect of glucose–insulin–potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial, JAMA, 293, 437, 10.1001/jama.293.4.437 Woods, 1992, Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2), Lancet, 339, 1553, 10.1016/0140-6736(92)91828-V 2002, Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial, Lancet, 360, 1189, 10.1016/S0140-6736(02)11278-5 Guan, 2003, Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction, J Cardiovasc Pharmacol, 41, 699, 10.1097/00005344-200305000-00005 1995, ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction, Lancet, 345, 669, 10.1016/S0140-6736(95)90865-X 1994, GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction, Lancet, 343, 1115 Faxon, 2002, The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study, J Am Coll Cardiol, 40, 1199, 10.1016/S0735-1097(02)02136-8 Mertens, 2006, Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial, Am Heart J, 152, e1 Mahaffey, 2003, Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial, Circulation, 108, 1176, 10.1161/01.CIR.0000087404.53661.F8 Granger, 2003, Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial, Circulation, 108, 1184, 10.1161/01.CIR.0000087447.12918.85 Ishii, 2005, Impact of a single administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction, Circulation, 112, 1284, 10.1161/CIRCULATIONAHA.104.530329 Kitakaze, 2007, Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials, Lancet, 370, 1483, 10.1016/S0140-6736(07)61634-1 Bär, 2006, Results of the first clinical study of adjunctive CAlderet (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study, Eur Heart J, 27, 2516, 10.1093/eurheartj/ehl304 Jang, 2008, Am Heart J, 155, e1 Tzivoni, 2009, Effect of caldaret on the incidence of severe left ventricular dysfunction in patients with ST-elevation myocardial infarction undergoing primary coronary intervention, Am J Cardiol, 103, 1, 10.1016/j.amjcard.2008.08.047 Atar, 2009, Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial, J Am Coll Cardiol, 53, 720, 10.1016/j.jacc.2008.12.017 Théroux, 2000, Inhibition of the sodium–hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial, Circulation, 102, 3032, 10.1161/01.CIR.102.25.3032 Zeymer, 2001, The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial, J Am Coll Cardiol, 38, 1644, 10.1016/S0735-1097(01)01608-4 Dixon, 2002, Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction, J Am Coll Cardiol, 40, 1928, 10.1016/S0735-1097(02)02567-6 Ly, 2005, A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study), Am Heart J, 150, 933, 10.1016/j.ahj.2005.02.049 O'Neill, 2007, Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention, J Am Coll Cardiol, 50, 397, 10.1016/j.jacc.2007.01.099 Jolicoeur, 2007, Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting, Am Heart J, 153, 732, 10.1016/j.ahj.2007.02.028 Takano, 2008, G-CSF therapy for acute myocardial infarction: studies of animal experiments give valuable hints to clinical trials, Int J Cardiol Sánchez, 2007, Present and future of stem cells for cardiovascular therapy, Ann Med, 39, 412, 10.1080/07853890701513746 Lipinski, 2007, Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials, J Am Coll Cardiol, 50, 1761, 10.1016/j.jacc.2007.07.041 Abdel-Latif, 2007, Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis, Arch Intern Med, 167, 989, 10.1001/archinte.167.10.989 Kang, 2008, Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials, Coron Artery Dis, 19, 327, 10.1097/MCA.0b013e328300dbd3 Martin-Rendon, 2008, Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review, Eur Heart J, 29, 1807, 10.1093/eurheartj/ehn220 Tendera, 2009, Eur Heart J Schächinger, 2006, Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction, N Engl J Med., 355, 1210, 10.1056/NEJMoa060186 Ince, 2007, Future investigations in stem cell activation with granulocyte-colony-stimulating factor after myocardial infarction, Nat Clin Pract Cardiovasc Med, 4, S119, 10.1038/ncpcardio0732 Fan, 2008, A meta-analysis of stem cell mobilization by granulocyte colony-stimulating factor in the treatment of acute myocardial infarction, Cardiovasc Drugs Ther, 22, 45, 10.1007/s10557-007-6072-9 Zohlnhöfer, 2008, Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis, J Am Coll Cardiol, 51, 1429, 10.1016/j.jacc.2007.11.073 Abdel-Latif, 2008, Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials, Am Heart J, 156, e9 Fan, 2007, Safety and efficacy of granulocyte colony-stimulating factor for patients with recent myocardial infarction: a meta-analysis, Int J Cardiol Ince, 2005, Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI), Circulation, 112, 3097, 10.1161/CIRCULATIONAHA.105.541433 Takano, 2007, Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction, Int J Cardiol, 122, 41, 10.1016/j.ijcard.2006.11.016 Ripa, 2006, Circulation, 113, 1983, 10.1161/CIRCULATIONAHA.105.610469 Engelmann, 2006, J Am Coll Cardiol, 48, 1712, 10.1016/j.jacc.2006.07.044 Zohlnhöfer, 2006, Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial, JAMA, 295, 1003, 10.1001/jama.295.9.1003 Coats, 2009, Ethical authorship and publishing, Int J Cardiol, 131, 149, 10.1016/j.ijcard.2008.11.048